An important breakthrough in understanding how inflammation is regulated has been made by scientists from Trinity College Dublin. They have just discovered that a key immune alarm protein previously believed to calm down the immune response actually does the opposite.

Their work has numerous potential impacts, especially in the context of understanding and responding to autoimmune disorders and inflammation.

Our immune system serves a very important function in protecting us from infection and injury. However, when immune responses become too aggressive this can lead to damaging inflammation, which occurs in conditions such as rheumatoid arthritis and psoriasis. Inflammation is triggered when our bodies produce “alarm proteins” (interleukins), which ramp up our defenses against infection and injury by switching on different components of our immune system.

Diagnosing cancer today is usually done via surgery, ultrasound scans, or blood tests. All of these methods are invasive and require a visit to a hospital…

S cientifically, it’s called ectogenesis, a term coined by J.B.S. Haldane in 1924. A hugely influential science popularizer, Haldane did for his generation what Carl Sagan did later in the century. He got people thinking and talking about the implications of science and technology on our civilization, and did not shy away from inventing new words in order to do so. Describing ectogenesis as pregnancy occurring in an artificial environment, from fertilization to birth, Haldane predicted that by 2074 this would account for more than 70 percent of human births.

His prediction may yet be on target.

In discussing the idea in his work Daedalus –a reference to the inventor in Greek mythology who, through his inventions, strived to bring humans to the level of the gods–Haldane was diving into issues of his time, namely eugenics and the first widespread debates over contraception and population control.

University of Southern California and the Cleveland Clinic Florida Research and Innovation Center researchers have published new research on GRP78, a protein implicated in both COVID-19.

First identified in 2019 in Wuhan, China, COVID-19, or Coronavirus disease 2019, (which was originally called “2019 novel coronavirus” or 2019-nCoV) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It has spread globally, resulting in the 2019–22 coronavirus pandemic.

The innovation was inspired by the measles virus.

In a world-first, researchers at Tel Aviv University have conceived of a way to control the encapsulation and release of drug molecules by exposure to UV light, according to a press release by the institution published on Monday.

The scientists now hope that this new efficient encapsulation will allow for the high loading capacity of molecules leading to further development of delivery systems for the controlled release of biomolecules and drugs in the body by external stimuli using light.